The Sackler family and Purdue Pharma, the maker of the addictive painkiller oxycontin, have reached a $7.4 billion settlement ...

Purdue Pharma’s owners from the Sackler family have struck a new ... “They basically created the playbook for marketing opioids.” She said the Sacklers and Purdue essentially helped spark the opioid ...

Purdue Pharma planned to exit bankruptcy last year under terms that ... Purdue will continue to be overseen by a monitor and will be prevented from lobbying or marketing opioids. "This story is about ...

Purdue Pharma planned to exit bankruptcy last year ... to be overseen by a monitor and will be prevented from lobbying or marketing opioids. "This story is about a family of cruel billionaires ...

They deny wrongdoing and stopped short of offering an apology for the impact of Purdue Pharma's involvement in the opioid market, centred around the promotion and marketing of its OxyContin ...

The latest settlement is meant to address a drug addiction crisis that has led to over 700,000 opioid overdose deaths in the US over the past two decades.

Colorado is set to receive around $81 million from a $7.4 billion preliminary settlement with Purdue Pharma, the company’s ...

A $7.4 billion settlement has been reached in principle between states, victims, and members of the Sackler family and Purdue ...

Family and company to make payment to group of US states and other parties to settle long-running litigation over OxyContin’s role in opioid epidemic ...

Officials in states and local governments claimed that the opioid crisis was exacerbated by Purdue Pharma’s OxyContin and ...

Purdue Pharma and the members of the Sackler family ... to be overseen by a monitor and will be prevented from lobbying or marketing opioids under the settlement. Purdue is the company that ...

The deal, agreed to by Purdue Pharma, the Sackler family members who own the company ... Connecticut-based Purdue said in a statement. Advertising Representatives for Sackler family members did not ...